項臨床第III期多中心、跨國、隨機、平行性、雙盲，評估BI 10773 (10mg, 25mg 每日口服一劑)相較於一般常規照護在心血管疾病高風險群之第2型糖尿病患者的心血管安全性試驗

CMUR > College of Medicine > School of Medicine > Research reports > Item 310903500/39817

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/39817

Title:	項臨床第III期多中心、跨國、隨機、平行性、雙盲，評估BI 10773 (10mg, 25mg 每日口服一劑)相較於一般常規照護在心血管疾病高風險群之第2型糖尿病患者的心血管安全性試驗
Authors:	張坤正(Kuan-Cheng Chang);張詩聖(Shih-Sheng Chang);張志斌(Chih-Ping Chang);王宇澄(Yu-Chen Wang);柯伯彥(Po-Yen Ko);楊晨佳(Chen-Chia Yang);盧炯睿(Chiung-Ray Lu)
Contributors:	醫學院醫學系學士班內科學科;中國附醫內科部心臟科
Date:	2011-10-10
Issue Date:	2011-08-24 11:39:53 (UTC+8)
Appears in Collections:	[School of Medicine] Research reports

Files in This Item:

There are no files associated with this item.